Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06054269
PHASE3

Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

Sponsor: Centers for Disease Control and Prevention

View on ClinicalTrials.gov

Summary

This randomized, double-blinded trial will assess humoral immune responses to adjuvanted, egg-based quadrivalent influenza vaccines compared to standard dose, egg-based quadrivalent influenza vaccines among healthcare personnel (HCP). The trial will be conducted at two sites in Lima, Peru during 2022 and 2023.

Official title: Randomized Controlled Trial, Double Blind, Phase III, to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among Health Care Personnel (EDUCATE)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

192

Start Date

2022-11-04

Completion Date

2026-03-31

Last Updated

2025-05-29

Healthy Volunteers

Yes

Conditions

Interventions

BIOLOGICAL

FLUAD Quadrivalent

0.5 mL intramuscular dose of FLUAD Quadrivalent

BIOLOGICAL

FluQuadri

0.5 mL intramuscular dose of FluQuadri

Locations (2)

Hospital Nacional Arzobispo Loayza

Lima, Peru

Hospital Nacional Cayetano Heredia

Lima, Peru